Orbital signet-ring cell lymphoma of diffuse, large, B-cell type

Can J Ophthalmol. 2013 Dec;48(6):e156-8. doi: 10.1016/j.jcjo.2013.08.008.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / metabolism
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Doxorubicin / therapeutic use
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / metabolism
  • Lymphoma, Large B-Cell, Diffuse / pathology*
  • Lymphoma, Large B-Cell, Diffuse / therapy
  • Male
  • Middle Aged
  • Orbital Neoplasms / metabolism
  • Orbital Neoplasms / pathology*
  • Orbital Neoplasms / therapy
  • Prednisone / therapeutic use
  • Proton Therapy
  • Tomography, X-Ray Computed
  • Vincristine / therapeutic use

Substances

  • Biomarkers, Tumor
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol